Table 2 Demographic findings of patients (n = 497)
From: Medication-related visits in a pediatric emergency department: an 8-years retrospective analysis
Characteristics | n(%, 95% CI) | |||
|---|---|---|---|---|
Age, mean (SD, CI 95%) | 3.2(2.9, 95% CI 0.31% to 0.37%)) | |||
age category | Â | |||
 0–2 y | 269 (54) | |||
 2–6 y | 168 (33) | |||
 6–14 | 60 (13) | |||
Gender | ||||
 girl | 225 (45) | |||
 Boy | 272 (55) | |||
Classification of MRVs (n = 497) | ||||
  Drug Use Without Indication | 257(51) | |||
  ADR | 152(30.3) | |||
  Supratherapeutic Dosage | 66(13.2) | |||
  Improper Drug Selection | 22(4.5) | |||
 True MRVs | 232 (46.5) | |||
  ADR | 152(65.5) | |||
  Medication related-ADRs | 87(37.5) | |||
  Vaccination Related-ADRs | 65(28) | |||
  Drug Use Without Indication | 46(19.8) | |||
  Supratherapeutic Dosage | 26(11.2) | |||
  Improper Drug Selection | 8(3.5) | |||
 Potential MRVs | 265 (53.5) | |||
  Drug Use Without Indication | 211 (79.6) | |||
  Supratherapeutic Dosage | 40(15.1) | |||
  Improper Drug Selection | 14(5.3) | |||
Degree of severity | ||||
|  | True MRVs (n = 232) | Medication related-ADRs (n = 87) | VACCINES (n = 65) | |
| Â | Mild | 50 (21.6, 95% CI 7.5% to 16.0%) | 16 (18.4) | 12 (18.5) |
| Â | Moderate | 156 (67.295% CI 60.7% to 73.2%) | 66 (75.8) | 52 (80) |
| Â | Severe | 26 (11.2, 95% CI 16.4% to 27.4%) | 5 (5.8) | 1 (1.5) |
Outcome | ||||
| Â | Hospitalization | 34(6.8) | ||
| Â | Death | - | ||